Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pictilisib in previously untreated advanced or recurrent NSCLC
NCT01493843Phase 2Completed
- Sponsor
- Genentech
- Start
- Jan 2012
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 2 trial of pictilisib in non-small cell lung cancer (NSCLC), sponsored by Genentech. Started Jan 2012; status: completed.
02
Drugs
pictilisib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01493843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01493843.